About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Hematology Branch
›
top-articles
Hematology Branch
1.2K
(top 0.1%)
papers
48.0K
(top 0.1%)
citations
110
(top 0.1%)
h
-index
176
(top 0.1%)
g
-index
1.2K
all documents
50.8K
doc citations
4.1K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
New England Journal of Medicine
2000
977
2
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Nature Medicine
2007
743
3
Telomere Diseases
New England Journal of Medicine
2009
723
4
Mutations inTERT,the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
New England Journal of Medicine
2005
665
5
Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation
Cell Stem Cell
2009
548
6
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
Blood
1995
493
7
Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro
Blood
1995
491
8
Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
New England Journal of Medicine
2012
454
9
BONE FORMATION IN VIVO: COMPARISON OF OSTEOGENESIS BY TRANSPLANTED MOUSE AND HUMAN MARROW STROMAL FIBROBLASTS
Transplantation
1997
452
10
Bmi1 regulates mitochondrial function and the DNA damage response pathway
Nature
2009
420
11
Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells
Blood
2003
404
12
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Cytotherapy
2016
400
13
Why Current Publication Practices May Distort Science
PLoS Medicine
2008
345
14
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Lancet Oncology, The
2015
344
15
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Blood
2008
337
16
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
Blood
2014
336
17
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Blood
2006
333
18
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Cell
2018
323
19
Regulation of CSF1 Promoter by the SWI/SNF-like BAF Complex
Cell
2001
315
20
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells
Blood
2009
312
21
Cellular Constituents of Immune Escape within the Tumor Microenvironment
Cancer Research
2012
308
22
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia
Blood
1995
306
23
Essentials of Th17 cell commitment and plasticity
Blood
2013
306
24
ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
Proceedings of the National Academy of Sciences of the United States of America
2009
305
25
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples
Nature
2015
303
26
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Nature Reviews Cancer
2018
299
27
Genotoxicity of Retroviral Integration In Hematopoietic Cells
Molecular Therapy
2006
276
28
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Blood
2017
276
29
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome
Blood
2003
274
30
Increased expression of Fas antigen on bone marrow CD34
+
cells of patients with aplastic anaemia
British Journal of Haematology
1995
268
31
Human Parvoviruses
Clinical Microbiology Reviews
2017
258
32
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Cytotherapy
2009
257
33
Label-Free Protein Quantification Using LC-Coupled Ion Trap or FT Mass Spectrometry: Reproducibility, Linearity, and Application with Complex Proteomes
Journal of Proteome Research
2006
244
34
Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells
PLoS Biology
2004
243
35
Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium
Scientific Reports
2016
240
36
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
Cancer
2019
229
37
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
Blood
2002
228
38
In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing
Lancet, The
2004
223
39
Aplastic anemia
Current Opinion in Hematology
2008
223
40
Bone marrow failure and the telomeropathies
Blood
2014
222
41
Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units
Blood
1997
216
42
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
Blood
2008
216
43
Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients With Coronary Artery Disease
Journal of the American College of Cardiology
2005
206
44
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Haematologica
2017
206
45
Rituximab in the treatment of acquired factor VIII inhibitors
Blood
2002
203
46
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Nature Reviews Drug Discovery
2015
203
47
A Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations
PLoS ONE
2009
201
48
Measurable residual disease testing in acute myeloid leukaemia
Leukemia
2017
197
49
Telomere maintenance and human bone marrow failure
Blood
2008
190
50
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
Blood
2007
189
site/software ©
exaly
; All materials licenced under
CC by-SA
.